Found: 29
Select item for more details and to access through your institution.
An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7).
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 805, doi. 10.3390/cancers13040805
- By:
- Publication type:
- Article
CRP and soluble CTLA4 are determinants of anti-PD1 resistance in gastrointestinal cancer.
- Published in:
- American Journal of Cancer Research, 2024, v. 14, n. 3, p. 1174, doi. 10.62347/NQBL9998
- By:
- Publication type:
- Article
Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 85, doi. 10.1159/000512821
- By:
- Publication type:
- Article
Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 4, p. 291, doi. 10.1111/ajco.12995
- By:
- Publication type:
- Article
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 7, p. 1, doi. 10.1007/s00432-024-05893-1
- By:
- Publication type:
- Article
Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269115
- By:
- Publication type:
- Article
Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257551
- By:
- Publication type:
- Article
Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin.
- Published in:
- In Vivo, 2024, v. 38, n. 2, p. 761, doi. 10.21873/invivo.13499
- By:
- Publication type:
- Article
PS02.133: THE EFFICACY AND SAFETY OF S-1 MONOTHERAPY FOR RECURRENT OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA REFRACTORY OR INTOLERABLE TO PLATINUM PLUS 5-FU.
- Published in:
- Diseases of the Esophagus, 2018, v. 31, n. 13, p. 158, doi. 10.1093/dote/doy089.PS02.133
- By:
- Publication type:
- Article
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 801, doi. 10.1007/s10147-024-02509-z
- By:
- Publication type:
- Article
Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 4, p. 595, doi. 10.1007/s10147-019-01598-5
- By:
- Publication type:
- Article
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.
- Published in:
- Supportive Care in Cancer, 2020, v. 28, n. 12, p. 5861, doi. 10.1007/s00520-020-05401-4
- By:
- Publication type:
- Article
Author Correction: The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Temporal dynamics from phosphoproteomics using endoscopic biopsy specimens provides new therapeutic targets in stage IV gastric cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08430-7
- By:
- Publication type:
- Article
The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-22718-8
- By:
- Publication type:
- Article
Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1009701
- By:
- Publication type:
- Article
Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 533, doi. 10.1007/s10637-019-00822-3
- By:
- Publication type:
- Article
Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 573, doi. 10.1007/s10637-018-0669-7
- By:
- Publication type:
- Article
Total neoadjuvant therapy followed by a watch-and-wait strategy for patients with rectal cancer (TOWARd): protocol for single-arm phase II/III confirmatory trial (JCOG2010).
- Published in:
- BJS Open, 2023, v. 7, n. 6, p. 1, doi. 10.1093/bjsopen/zrad110
- By:
- Publication type:
- Article
Clinical outcomes of surgical and imatinib treatment for rectal gastrointestinal stromal tumours: retrospective cohort study.
- Published in:
- BJS Open, 2022, v. 6, n. 3, p. 1, doi. 10.1093/bjsopen/zrac067
- By:
- Publication type:
- Article
Temporal dynamics from phosphoproteomics using endoscopic biopsy specimens provides new therapeutic targets in stage IV gastric cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08430-7
- By:
- Publication type:
- Article
Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real‐world analysis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cam4.7401
- By:
- Publication type:
- Article
Progression patterns and site‐specific responses in advanced gastric cancer patients treated with nivolumab.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 9322, doi. 10.1002/cam4.5689
- By:
- Publication type:
- Article
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 2, p. 595, doi. 10.1002/cam4.2708
- By:
- Publication type:
- Article
A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 3, p. 439, doi. 10.1007/s10120-017-0753-2
- By:
- Publication type:
- Article
Current status and perspectives of immune checkpoint inhibitors for colorectal cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 10, doi. 10.1093/jjco/hyaa200
- By:
- Publication type:
- Article
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 5, p. 412, doi. 10.1093/jjco/hyz034
- By:
- Publication type:
- Article
WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF<sup>V600E</sup> Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study).
- Published in:
- 2022
- By:
- Publication type:
- journal article